SC 13G
MEREO BIOPHARMA GROUP PLC.
- Company
- Mereo BioPharma Group plc
- Filed
- February 5, 2024
- Accession Number
- 0000902664-24-001056
A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →